Post-Launch Tracking Surveys
Learn how a pharma company partnered with MMIT’ to understand payer perceptions of its brand over time as competitors enter the market....
Value Proposition Message Testing
Learn how a pharma company preparing for a drug launch partnered with MMIT to gain insight into the most effective messaging with payers....
Meet the Expert: Navigating the Complex U.S. Payer Landscape to Grow Your Business
Understanding a large complex payer and their subsidiaries to segment your contracting plan or recognizing lives enrollment shifts in specific geographies, having payer data source solution to support your sales and...
Meet the Expert: Tracking Access in Real-Time
Payer coverage policies continue to become more complex with increasing access hurdles. Dig into ways to sift through the noise and uncover payer account intervention and pull-through opportunities via dashboards an...
Tips to Engage Pharma Manufacturers
Without the right tools, your account managers will face many obstacles trying to win more pharma business. We'll give you our top tips on how to engage with pharma manufacturers and differentiate your organization....
Neutropenia
MMIT’s P&T Persectives on Neutropenia reviewed Rolontis® (eflapegrastim), a new long-acting rhG-CSF therapy for patients with chemotherapy induced neutropenia....
Financial considerations for Rolontis® (Contracting Pharmacist)
MMIT’s P&T Persectives on Neutropenia reviewed Rolontis® (eflapegrastim), a new long-acting rhG-CSF therapy for patients with chemotherapy induced neutropenia....
What shifts have been observed by Oncologists in the treatment of Neutropenia? (Oncologist 2)
MMIT’s P&T Persectives on Neutropenia reviewed Rolontis® (eflapegrastim), a new long-acting rhG-CSF therapy for patients with chemotherapy induced neutropenia....
Does Neulasta® Onpro® retain any advantages as the only on-body injector? (Oncologist)
MMIT’s P&T Persectives on Neutropenia reviewed Rolontis® (eflapegrastim), a new long-acting rhG-CSF therapy for patients with chemotherapy induced neutropenia....